This suggests that the high expression of CD34/CD276 may promote a more complex tumor extracellular microenvironment, thus promoting the immune escape of CRC, which is consistent with the best KEGG pathway for GSEA enrichment analysis. The gene discussed is CD276; the disease is colorectal carcinoma.